Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Dusso

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Kidney International|May 1, 1993
Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cellsR G Carlini, A S Dusso, C I Obialo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1997
A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor contentF Takahashi, J L Finch, M Denda, et al.
Kidney International|March 7, 2001
p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growthA S Dusso, T Pavlopoulos, L Naumovich, et al.
Kidney International. Supplement|July 1, 2006
Pathogenic mechanisms for parathyroid hyperplasiaA S Dusso, T Sato, M V Arcidiacono, et al.
Contributions to Nephrology|January 1, 1991
The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretionY Nishii, J Abe, T Mori, et al.
Endocrinology|June 1, 1992
The effect of 22-oxacalcitriol on serum calcitriolA S Dusso, L Negrea, J Finch, et al.
Endocrinology|April 1, 1991
On the mechanisms for the selective action of vitamin D analogsA S Dusso, L Negrea, S Gunawardhana, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Kidney International|May 1, 1993
Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cellsR G Carlini, A S Dusso, C I Obialo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1997
A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor contentF Takahashi, J L Finch, M Denda, et al.
Kidney International|March 7, 2001
p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growthA S Dusso, T Pavlopoulos, L Naumovich, et al.
Kidney International. Supplement|July 1, 2006
Pathogenic mechanisms for parathyroid hyperplasiaA S Dusso, T Sato, M V Arcidiacono, et al.
Contributions to Nephrology|January 1, 1991
The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretionY Nishii, J Abe, T Mori, et al.
Endocrinology|June 1, 1992
The effect of 22-oxacalcitriol on serum calcitriolA S Dusso, L Negrea, J Finch, et al.
Endocrinology|April 1, 1991
On the mechanisms for the selective action of vitamin D analogsA S Dusso, L Negrea, S Gunawardhana, et al.
Pageof 2